Health Action: Special issue on TB (March 2013)
-
Upload
curiouscroll -
Category
Documents
-
view
216 -
download
0
Transcript of Health Action: Special issue on TB (March 2013)
-
7/29/2019 Health Action: Special issue on TB (March 2013)
1/40
Health Action March 2013 1
-
7/29/2019 Health Action: Special issue on TB (March 2013)
2/40
Health Action March 2013 2
A HAFA NATIONAL MONTHLY FROM
THE HOUSE OF THE CATHOLIC HEALTH
ASSOCIATION OF INDIA (CHAI)
MANAGING EDITORRev. Dr. Tomi Thomas, IMS
EDITOR-IN-CHARGEN Vasudevan Nair
EDITORIAL ASSISTANTTheophine V. John
LAYOUT & PAGE MAKE-UP
M S Nanda KishoreCIRCULATION SUPPORTT K Rajendran
EDITORIAL BOARD
Rev Dr Yvon AmbroiseSr Anne Ponnattil
Dr B Ekbal
Dr Amarender Reddy
Dr M V Ramana Rao
Dr Ravi DSouza
Ravi Duggal
EDITORIAL ADVISORY COMMITTEE
Dr Sunny Chunkapura
Dr S Ram MurthyDr P Sangram
Dr Gopala Krishna
Dr Venugopal Gouri
M C Thomas
Dr P V Sharada
Printed and Published by Dr (Sr) Placida
Vennalilvally for and on behalf of Health
Accessories for All (HAFA) at Jeevan Institute of
Printing, Sikh Village, Secunderabad- 500 009
Editorial and Administrative Offices:Post Box 2153, 157/6, Staff Road, GunrockEnclave, Secunderabad 500 009, AP, IndiaTel: 27848293, 27848457, Fax: 040-27811982, E-mail: [email protected];h e a l t h a c t i o n @ c h a i - i n d i a . o r g ;[email protected]: www.chai-india.org; hafa-india.org
Articles and statements in this publication do
not necessarily reflect the policies and views
of HAFA.Information given here is not a
substitute for professional medical advice.
Subscription Rates
India Foreign
Annual Rs.300 Annual US $ 50Life (12Years.) Rs.2500 Life US $ 500Single Copy Rs. 30
Thought for the Month
health
action
Health Action March 2013
Vol 26 No.3 MARCH 2013
Contents
Cover: Editorial Team
Picture courtesy:
Cover and Text: Google.com
Everything we hear is an
opinion, not a fact. Everything
we see is a perspective, not the
truth.
Marcus Aurelius
Tuberculosis:what, why and how
Dr Anand Das .................................. 4
Engaging communities in the
fight against TB
Project-Axshya Programme
Management Unit....................... 8
Evolving TB control strategies in .
India
Courtesy: Central TB Division..... 11
Tuberculosis and silicosis at
workplace
Axshya India team of TB Alert...... 14
Experiences of Lepra India in
TB control in Andhra Pradesh
Drs J Subbanna & Aparna S
Srikantam..................................16
TB in childrenDr Shoma A Chatterji................. 18
Social stigma attached to TB
Dr G Srinivas Rao..................... 20
Frequently-asked questions on TB
Source: TBC India ......................21
Knowledge, attitudes andpractices on TB
Courtesy: The Union ................... 22
World TB day: 24 March 2013Vinay Kumar G......................... 24
Project Axshya has helped thestate in reaching the unreached
Interview with Dr S Jayasankar,
State TB Officer, Government ofKerala........................................ 25
Why should BPL TB patients be
included in the food security
bill?.................... ....................26
CHAI-Axshya: the global fund
round 9 TB project
Rev Dr Tomi Thomas, IMS ..........27
District TB officers speak........ 30
TB patients, communities,RHCPand TB forum members
testify................................... 32
Reducing stress in type 2 diabetic
patients through yoga
Shanthi and Karoline Rajkumar...33
Rediscovering the forgotten
millets... for health
Aparna Kuna et al ......................35
Vaccinaion in children
Suchitra B.S............................ 37
Health bits...............................38
-
7/29/2019 Health Action: Special issue on TB (March 2013)
3/40
Health Action March 2013 3
EDITORIAL
Rev Dr Tomi Thomas, IMS
Managing Editor
When India woke up to her sixty-fourth Republic Day the thought that was uppermost in the mind of anaverage Indian might have been about the life-situation in the country which is far from what one wouldwish it were. A Republic of ideas, dreams and imagination has become one of hate and nightmares. Livingcondition is below mediocre. Unemployment is massive. Healthcare is abysmal. Education is in a shambles. Thereis massive corruption. There is misgovernance or lack of governance. Assaults on democratic values from withinand without and violation of womens rights, dignity and lives are rampant. And costly are the grievous failures toaddress the inequalities and the mass and multiple deprivation that plague the lives of millions of people.
Our national aim should be to transform India into a powerful, secular, industrial or economic powerhouse whereeveryone can lead a decent and healthy life. In this task each individual has to chip in with their creativity andinitiatives. In spite of three decades of high economic growth, social progress continues to elude us. For India toreap rich dividends from its democracy, it requires an educated, skilled and healthy workforce to compete in aglobal economy. A manifold increase in funding for education and health coupled with copious reduction in expenditureand waste, subsidies and warfare is the need of the hour.
India recently marked a major milestone: two years without a single case of polio. The success of fighting poliowas the result of a concerted effort that included strong leadership and commitment of the government as well asclose partnership between public and private sectors. The world is in the cusp of eradication. We are not yet there.As regards leprosy it is the same story. It was announced that leprosy had been virtually eradicated. But the curseis very much here. In 2010, out of 2,28,000 cases in the world, India accounted for 1,26,000. We need to step upeffort to achieve zero-prevalence (Times of India, 29 January, 2013).
Indias TB burden is staggering. Every year, 1.8 million people get the disease; and about 800,000 cases areinfectious. Until recently, 370,000 died of it annually. An estimated 100 million workdays are lost to it, with thecountry incurring a huge cost nearly $3 billion. The direct costs are $ 300 million. Since its launch in 1998 throughRevised National Tuberculosis Control Programme, more than 14.2 million patients have been treated and 2.6million lives saved with DOTS.(The Hindu, 21 October, 2012)
Around 99,000 Indians suffering from TB become drug-resistant every year. In India, around 3% of all newcases and 12-17% among treatment cases are MDR. In 2010, 2.3 million cases occurred of which 360,000 peopledied; nearly 1000 deaths per day. (Times of India, 8 August 2012). An easy and effective way to diagnose TBhas remained a challenge. Emergence of drug-resistance has made its management more complex.
MDR TB is caused by bacteria that are resistant to anti-TB drugs (isoniazid and rifampicin). XDR TB iscaused by bacteria that are resistant to isoniazid and rifampicin as well as any fluoroquinolone and second line anti-TB injectable drugs. Sixty-nine countries including India have reported cases of XDR-TB. An estimated 25000cases of XDR TB emerge every year. (Times of India 21, October 2012)
Earlier, the focus was on detection to encourage people to go for a check-up and sputum testing. But withMulti Drug Resistant TB cases proliferating, the focus is more on completion of the first course which is thesimplest way to defeat resistance.
The Project Axshya is a civil society initiative to strengthen TB care and control in India. It is the largestAdvocacy, Communication and Social Mobilization (ACSM) initiative supported by Global Fund Round 9 Grantand is being implemented in 375 districts across 23 states by the UNION and World Vision India ably assisted bya network of civil society organizations. The project takes a holistic approach towards improving tuberculosisquality care and control. In its second phase, by the time the project closes, perceptible difference would havebeen made to the tuberculosis situation in the country. Let us hope our dream of a TB-free India comes true!
The Catholic Health Association of India (CHAI), the biggest sub-recipient of the UNION, as part of its advocacyeffort, took up with the government the idea of providing additional nutritional support to the BPL TB patients byincluding them in the Food Security Bill. This will ensure their completion of treatment.
This issue deals in depth with the care and control of tuberculosis.
Improving access to tuberculosis care and control
-
7/29/2019 Health Action: Special issue on TB (March 2013)
4/40
Health Action March 2013 4
Tuberculosis (TB) is a disease of great antiquity.
Tuberculous lesions had been found in the
vertebrae of Neolithic humans and Egyptian
mummies as early as 3700 BC.Today, tuberculosis has become the most important
communicable disease in the world. In 2011, there were
an estimated 8.7 million new cases of tuberculosis (13%
co-infected with HIV) and 1.4 million people died from
tuberculosis, including almost one million deaths among
HIV-negative individuals and 430 000 among people
who were HIV-positive. TB is one of the top killers of
women, with 300 000 deaths among HIV-negative
women and 200 000 deaths among HIV-positive women
in 2011.
PathogenesisRobert Koch first described the
tubercle bacillus known as
Mycobacterium tuberculosis in
1882. Mycobacteria are known to
comprise a large group of acid-fast,
alcohol-fast aerobic or
microaerophilic, non-spore forming,
non-motile bacilli. Of the many
different mycobacteria, only M
tuberculosis, M bovis and M
africanum are recognized as tubercle bacilli, all being
sub-species of a single species. M tuberculosis is an
obligate parasite that is infectious to humans, other
primates and many other mammals.
TransmissionFor many years, TB was thought to be transmitted
genetically. It is now known that the infection is
transmitted through the airborne route and that the unit
of infection is a small particle called the droplet nuclei.
Successful transmission requires airborne infectious
droplet nuclei to be small enough to reach an alveolus
COVER
STORY Tuberculosis
What, Why and How
Dr Anand Das (MBBS, DTCD, DNB)
in the periphery of the lung. There is a critical diameter
range that maximizes the probability of inhalation and
retention of infectious particles leading to the
establishment of the infection. The diameter lies
somewhere between 1 mm and 5 mm.
The risk between infection and progression to disease
is multifactorial. The risk gets elevated in the first years
following infection and then remains low for a prolonged
period of time. Other risk factors include HIV infection,
lung diseases such as silicosis, carcinoma of the head
and neck, immunosuppressive treatment, smoking,
diabetes and surgeries like gastrectomy and jejenoileal
bypass.
PathologyDeposition of TB bacilli in the lung
alveoli is followed by vasodilatation
and an influx of polymorphonucleo-
cytes (PMNs) and macrophages to
the area. After several weeks, the
PMNs decrease and macrophages
predominate. The macrophages
crowd together as epitheloid cells to
form the tubercle or the unit lesion
of tuberculosis. Some mononuclear
cells fuse to form the multinucleated
or Langhans giant cell.
Lymphocytes surround the outer margin of the tubercleand in the centre of the lesion a zone of caseous necrosis
may appear that may subsequently calcify. Primary,
infection is usually evident as a subpleural tubercle (the
Primary or Ghons focus) in any lung zone and drains
via lymphatics to hilar lymph node to form the primary
complex.
Most primary infection heals although haematogenous
spread probably occurs via the lymphatics in majority
resulting in seeding of the bacilli to other parts of the
lung as well as other organs. The primary lesion
-
7/29/2019 Health Action: Special issue on TB (March 2013)
5/40
Health Action March 2013 5
sometimes progresses and the pathological changes are
similar to those seen in reactivation tuberculosis.
Reactivated pulmonary tuberculosis is most often seen
in the upper lung zones and limited to the posterior
segment of the upper lobe or the apex pf the lower
lobe.
The high ventilation-perfusion ratio with alveolar Po2
elevated relative to other zones, predisposes to
reactivation at these sites. Proliferation of the bacilli in
the caseous centres is followed by softening and
liquefaction of the caseous matter, which may discharge
into the bronchus with resultant cavity formation.
Whereas approximately 104 bacilli per gram are fund
in caseous tissue, upto 109 organisms may be harboured
in a single cavitory lesion. Fibrous tissue around the
lesion, is incapable of limiting the extension of
tuberculosis process. Spread of caseous material mayresult in development of tuberculous pneumonia.
Rupture of caseous pulmonary focus into blood vessel
may result in military tuberculosis (0.5 to 2mm
tuberculous foci) in the lung and other organs.
Encroachment of pulmonary or lymph node caseous
material on the bronchi may lead to tuberculous
bronchitis. Rupture of caseous glands into the trachea
or major bronchus may cause collapse of lung or even
sudden death by suffocation in young children.
ImmunologyThe immune or antimycobacterial response of
previously infected individuals to subsequent
mycobacterial challenge is mediated by a population of
mononuclear phagocytes that ingested and killed TB
bacilli in an increased rate compared with normal
macrophages. Cell-mediated immunity is alone
responsible for this acquired resistance. The immunity
transferred by an initial infection is utilized in the form
of BCG vaccination. BCG confers immunity by
activation of macrophages within the reticuloendothelial
cells of the immunized host with resultant limitation of
mycobacterial growth on subsequent challenge.
The positive tuberculin test is the earliest indicator of
infection with TB. However, a negative tuberculin test
does not exclude tuberculosis. Negative tuberculin tests
may be found in patients with military TB, extensive
disease and elderly.
Patterns of presentation (Timetable)
Most primary TB heals spontaneously without residueon the chest film. In some patients there may be
sequelae to the primary infection. In children, enlarged
hilar lymph node may compress or erode bronchi with
resultant lobar consolidation and collapse called
epituberculosis.
Miliary tuberculosis and tuberculosis meningitis occur
usually within 6 months of primary infection and is
common among children less than 5 years old. Pleural
effusion, due to seeding of the pleura from a lung focus,
occurs within 6 to 12 months and is commoner among
younger adults. Increasing infiltration and cavitation
called progressive primary or post-primary disease
occurs 1 to 2 years after the primary infection. Skeletal
tuberculosis, most commonly of the spine, could occur
1 to 5 years after primary infection. Genitourinary
tuberculosis commonly occurs 5 to 15 years after
primary infection.
EpidemiologyMorbidity
Age: Median age of TB patients has increased
markedly in countries where the risk of infection
declined rapidly and thus the infected populationsegments became increasingly older. In contrast, in
low income countries, Tb notification rate still peaks
in young adults.
Sex: Risk of progression from infection to disease
also differs among males and females and varies
depending on the age. The M:F (male-female) ratio
of 2:1 explains higher prevalence of infection among
males.
Socio-economic Status: There is a strong association
of poverty with the incidence of TB. Low socio-
economic conditions lead to increase in transmission.
Today tuberculosis has become the most
important communicable disease in the
world. In 2011, there were an estimated
8.7 million new cases of tuberculosis (13%
co-infected with HIV) and 1.4 millionpeople died from tuberculosis, including
almost one million deaths among HIV-
negative individuals and 430 000 among
people who were HIV-positive. TB is one
of the top killers of women, with 300 000
deaths among HIV-negative women and
200 000 deaths among HIV-positive
women in 2011.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
6/40
Health Action March 2013 6
Poverty is also associated with
reduced access to health care
services.
Race and Ethnicity: The decline
in incidence in the US has beenthe greatest among the 5 to 14
year-old, greater among females
than males and more pronounced
among the white.
Migration: High incidence among
South-East Asian refugees
appears because of high risk of
tuberculosis infection in their
countries of origin.
Population Density: Age-specific
prevalence is frequently lower in
rural than in urban areas. Marital Status: Highest incidence
found in men who were divorced
and lowest incidence was found in married men.
Single and widowed men had an incidence between
the two extremes.
Substance Abuse: Despite the long-standing notion
between alcohol and other substances and incidence,
the epidemiological evidence of a causal association
is not convincing.
Other Risk Groups: Health care workers are at an
increased risk. Impact of HIV Infection: TB and HIV are two
conditions that are intrinsically linked as the prevention
of TB depends on the integrity of Cell Immune System
and HIV destroys precisely that. HIV may alter the
epidemiology in three ways:
Endogenous reactivation in persons
who become HIV-infected
Progression from infection to disease
in pre-existing HIV-infected individuals
Transmission of TB to general
population from individuals who
developed TB because of HIV
infection
Mortality
Major site of disease: Sputum-positive pulmonary
tuberculosis has a higher fatality rate than sputum
negative.
Delay in diagnosis and treatment: Failure to diagnose
may result in death as well as unrecognized
transmission to family and friends.
Age: Mortality is highest among young adults.
Industrialization: Spanning 300 years, the epidemic is
coming to an end.
Official estimates: 1.5 million deaths/
year (Difficult to verify)
Chemoprophylaxis: Administration of
chemotherapy (use of chemicalagents to treat or control disease) to
prevent the development of
tuberculosis disease
Primary: Given to individuals who
have so far not been infected.
Isoniazid is used based on its value in
experimental animals.
Secondary (or disease): Household
contacts, Positive TB skin test reactors
with abnormal but inactive X Ray,
positive skin test in special clinicalsituations are given 300 mg INH daily
for prevention of development of
disease.
Clinical features
Symptoms Symptom-free, discovered on routine chest
radiography
Persistent cough with or without expectoration
Malaise
Loss of appetite and weight loss
Recurrent colds Low-grade fever, evening rise of temperature
and night sweats
Physical Signs Pallor, hectic flush or cachexia
For many years, TB was thought to be
transmitted genetically. It is now known
that the infection is transmitted through the
airborne route and that the unit of infection
is a small particle called the droplet nuclei.Successful transmission requires airborne
infectious droplet nuclei to be small
enough to reach an alveolus in the
periphery of the lung. There is a critical
diameter range that maximizes the
probability of inhalation and retention of
infectious particles leading to the
establishment of the infection.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
7/40
Health Action March 2013 7
Increased pulse rate and respiratory rate (if febrile)
Clubbing (Rare)
Post-tussive crepitations in upper zones and apices
Advanced or pneumonic disease: signs of
consolidation
Chronic disease: deviation of trachea due to fibrosis
Physical signs of cavity: seldom found even with large
cavities
Localized wheeze: endobronchial tuberculosis
Diagnosis Sputum smear examination: ZN staining
LED FM Microscopy
Culture : Solid and LPA
Xpert MTB/RIF (MTB integrated cartridge-based
automated nucleic acid amplification test (CB-
NAAT) that uses a common platform to diagnose
both TB and Rifampicin resistance), which has a
sensitivity and specificity equivalent to that of solid
culture, while providing the results rapidly within 2
hours.
Bacteriological examination of samples other than
sputum: Gastric aspirate, Laryngeal swabs, Fibreoptic
bronchoscopic specimens (bronchial washings,
brushings or transbronchial biopsies), Transtracheal
aspirates, FNAC etc.
Radiology: Opacities mainly in upper zones, patchy
or nodular opacity, presence of cavity/cavities,
calcification, bilateral opacities in upper zones,opacities that persist even after several weeks.
Assessment of activityIt is often difficult to decide whether a particular lesion
should be treated or merits further assessment. The
following may give some guidance:
Bacteriologically positive patient indicates activity and
is an absolute indication for treatment
Symptoms such as cough, hemoptysis, tiredness and
weight loss are suggestive that a lesion demonstrated
radiologically is active
Persistent crepitations
Certain radiological appearances: cavity, widespread
soft shadows, shadows that extend on serial chest x
rays
Clinical features in the HIV-positive patientWhen TB occurs late in the course of HIV infection
or in patients with AIDS, the features are more atypical:
lower zone or diffuse consolidation, mediastinal
adenopathy and involvement of extrapulmonary sites
like brain, pericardium, bones and gastro-intestinal tract.
Cavitation of pulmonary lesions and tuberculin positivity
are less common.
Differential diagnosis of pulmonary
tuberculosis Pneumonia: sputum-positive for TB and radiographic
opacities not improving in 2 -3 weeks Carcinoma of the bronchus: Consolidation distal to a
proximal carcinoma particularly may be cavitated and
mimic TB. Sputum examination and CT, FNAC and
transbronchial biopsy may be done.
Lung abcess due to Staphylococcus pyogenes and
Klebsiella: Acute severe illness with marked
leucocytosis and organism readily isolated from blood
or sputum
Pulmonary infarcts: Upper zone infarcts with
cavitations may mimic TB. Routine investigations,
deep vein thrombosis and improving serial x rays helpdifferentiate
Other pulmonary diseases: Atypical mycobacteria is
a frequent source of confusion.
Complications Pleurisy : a classical pleural rub may be heard
Tuberculous empyema: Following artificial
pneumothorax therapy and can present thirty years
after therapy. Could result from the rupture of a
cavity in the pleural space. Chemotherapy, tube
suction and decortication may be needed.
Tuberculous laryngitis: Laryngoscopy and biopsy maybe needed to establish diagnosis.
TB of other organs: Testes in males and urine
examination should be done.
Chronic obstructive airway disease: May result from
a severe fibrotic pulmonary disease.
Corpulmonale: Distortion of pulmonary parenchyma,
emphysema and airways obstruction.
Miliary tuberculosis and tuberculosis
meningitis occur usually within 6 months
of primary infection and is common
among children less than 5 years old.
Pleural effusion, due to seeding of the
pleura from a lung focus, occurs within 6
to 12 months and is commoner among
younger adults.
(*Technical Officer, International Union Against Tuberculosis
and Lung Diseases, The Union South-East Asia Office, C-6,
Qutub Institutional Area, New Delhi 110 016. Email:
-
7/29/2019 Health Action: Special issue on TB (March 2013)
8/40
Health Action March 2013 8
Revised National Tuberculosis Programme(RNTCP) was initiated in 1997 and expanded
at an unprecedented scale to cover the entire
country by March 2006. During this expansion phase(called phase 1) the programme, focused on enhancing
political and administrative commitment, establishing
quality diagnostic and treatment services through publichealth facilities, systematic supervision and monitoring
and accountability towards TB care and control.
In the years to follow (2006-11) the programme
focused on universal access to TB services, in line with
the Millennium Development Goals, with DOTS strategyat its core.This strategy also took cognizance of six key
strategies proposed by the global Stop TB strategy
of WHO (2006-2015) to have World Free of TB.Strengthening involvement of civil society through NGO
and Private Provider schemes, Advocacy,
Communication and Social Mobilization (ACSM) began
to appear on the programme agenda in this phase.Currently, the proposed National Strategic Plan (NSP)
document for Phase III (2012-17), emphasizes earlycase detection and improved diagnosis of all TB patients
with better outreach, increased case finding,
involvement of private providers and community-basedsupervision, monitoring and accountability to TB care
and control.
Early case-detection and ensuring complete treatment
of sputum-positive TB clients has always been a major
public health challenge for TB control programme. The
programme strategies adopted were able to cater toonly those clients who visited public health institutions
or those who were identified by community-basedhealthcare workers. Clients outside the public health
network continued to go undiagnosed and untreated
thereby increasing the TB burden in community. Thus
community engagement strategies were to be developed
to create awareness about TB care and control. In the
process, Project Axshya evolved with objectives to
expand reach, visibility and effectiveness of RNTCPby engaging community-based providers to improve TB
COVER
STORY Engaging communities in
the fight against TBservices, especially for women and children,
marginalized, vulnerable and TB-HIV co-infectedpopulations. The Union, being the oldest organization
working in TB care and control with a mission to bring
innovation, expertise, solutions and support to addresshealth challenges partnered with RNTCP, World Vision
India to implement the largest ACSM project ProjectAxshya. The project supported by Global Fund Round
9 grant, is implemented by the Union in 300 districts
across 21 states of India through a network of partnersfrom nine civil society organizations.
Over a period of two years, the project has been able
to network with over 1200 NGOs and 3000 CBOs who
are involved in the implementation of ACSM activities
at the community level.Activities listed in the table are all interlinked to
-
7/29/2019 Health Action: Special issue on TB (March 2013)
9/40
Health Action March 2013 9
Thematic areas Activities
Community Engagement Community Group Meetings(GaonKalyanSamitis)
Engage/Train Community
Volunteers
Mass Media Campaign
(Bulgam Bhai - campaign)
Mid Media Activities
Axshya Village (TB Free Villages)
Empowering TB-Affected Communities Dissemination of Patient Charter
District TB Forums
Sensitizing people affected by HIV
Engaging Healthcare Providers Engaging Rural Healthcare Providers
Engaging AYUSH Providers
Health Systems Strengthening Sputum collection and
transportation
Human resource development
component
Health infrastructure support
component
Default retrieval
Sensitization of NGOs on RNTCP
scheme
Technical support to CTD, State
TB cell in areas of ACSM
Capacity building of program staff
on MDR TB, OR, Epidemiology and
Health Management
Other Advocacy Efforts Enhancing political and
administrative commitment.
Engaging professional
associations
Supporting national partnership
for TB care and control.
Activities of Project Axshya
engaging communities advocating for TB care and
control (identifying symptomatics, sputum collection andtransportation, referrals, treatment adherence,
completion, default retrieval etc); Informing
communities through communication tools about TB,rights and responsibilities of patients through patient
charter, and service availability at health facilities;
Mobilizing communities to advocate for political and
administrative commitment in ensuring services at health
facilities and also for creating awareness about TB
more specifically to reduce TB stigma. Community
engagement involves people from all sectors of thesociety. In Project Axshya through
GaonKalyan Samitis the focus has been
(a) to involve members of Village
Health Sanitation and Nutrition
Committees (VHSNCs), Self-HelpGroups, Panchayati Raj Institutions,other influential people through
community group meetings. (b) to build
capacity and sensitization of local health
care providers - Rural health care
providers (RHCPs), Ayurveda, Yoga
and Naturopahty, Unani, Sidha andHomeopathy (AYUSH) providers, soft
skill training for health staff and other
private providers in referrals/
management of referrals. (c) to build
capacities of volunteers in hard-to-
reach areas, marginalized and
vulnerable populations (eg. HIVaffected, tribal, naxal affected areas,
slums etc), for identifying
symptomatics, collection of sputum and
transportation to nearest DMCs and
support the system/programme in
tracing lost to follow-up of patients ontreatment.
Gaon Kalyan Samiti
Gaon Kalyan Samiti (GKS) meetingsare organized by volunteers of partner
NGOs at village level and or at wardlevel (in Urban areas). During the
meetings, (a) the members are
sensitized about TB care and control,(b) information is provided about
availability of services eg. Name of the
DMC, TU, etc (c) facilitate volunteersin identifying TB symptomatics in
community (d) inform about patients
rights and responsibilities through Patient Charter (e)
support TB patients in social acceptance eg. Toovercome stigma, (f) support treatment adherence etc.
Nearly 36,000 such meetings have been conducted
across 21 states of India. In addition to GKS, Axshyavillage concept is implemented. This intervention is
aimed at community awareness, engagement and
empowerment on TB care and control.
Communities in India access private health care
providers (~90%) for any type of illness. Privateproviders often are the first-point of contact, and
awareness about TB among them is most important for
Table 1
-
7/29/2019 Health Action: Special issue on TB (March 2013)
10/40
Health Action March 2013 10
TB care and control. Limited knowledge or lack of
knowledge has been found to contribute to poor
adherence to treatment regimen prescribed underRNTCP. As a result of non-adherence to treatment
regimen, the burden of multi-drug resistant form of TB
tends to increase in communities. It was thereforeenvisaged under Project Axshya to engage private
providers most importantly RHCPs (unqualified
providers) in the identification of symptomatics,referrals, treatment (completion) and default retrieval.
Currently, about 17,000 RHCPs have been sensitized
under project and are referring TB symptomatics,engaged in sputum collection and transportation and are
recognized as DOT providers under RNTCP. DCs and
the other project staff have strongly advocated for the
involvement of these unqualified practitioners inreferrals & DOT provision as they are usually the first
point of contact for the community members.
Empowering TB communitiesEmpowering TB communities through TB forums is
an innovative approach. TB forums aim to serve as a
platform to share the experiences of TB patients.
Formation of this forum is facilitated by the project at
the district level ensuring representation from TB
affected patients (cured/on treatment) and civil societymembers journalist, lawyers, NGO representatives,
Opinion leaders etc. to discuss the overall experience
of TB-patients and suggestions to improve TB care
services. The forum meets regularly with DTOs/other
officials to brief them about the issues and challenges
faced by the patients. Through Project Axshya, TB
patients have also been made aware of their Rights &Responsibilities by means of Patient Charter. This is a
tool that informs TB patients about TB disease per
se, patient entitlements, responsibility of patient towardscommunity and family members.TB patient
representation in TB forums, also discuss about their
rights to get free diagnosis and treatment and other
benefits under the existing social welfare schemes.
Health systems strengtheningThe cycle of community engagement would be
incomplete without Health System support/strengthening. Health System support/strengthening forAxshya comes from partnering with Central TBDivision, Ministry of Health and Family Welfare. TheUnion has extended support to CTD in terms of providingtechnical support in areas of ACSM, PP and Monitoringand Evaluation (M&E).ACSM support is also providedto RNTCP in six states namely Karnataka,Maharashtra, Madhya Pradesh, Uttarakhand, UttarPradesh and Punjab through the 6 Union consultants.At the district level, activities are focused at sputumcollection and transportation in areas of vulnerable/
marginalized/hard-to-reach, poor case detection etc.Secondly to support DTCs in default retrieval throughthe network of volunteers established under projectAxshya. Thirdly, soft-skill training has been provided tohealth staff to impart communication and counsellingskills, improve Inter Personal Communication (IPC)which helps in better patient-provider communicationand building healthy relationships. Fourthly, in manystates, Designated Microscopic Centres (DMCs) havebeen supported through providing quarterly preventivemaintenance of the binocular microscopes therebyensuring quality sputum microscopy and hence, betterdiagnostic care to TB patients. These are some of themajor areas of support provided through ProjectAxshya. The District Tuberculosis Officers (DTOs),State Tuberculosis Officers (STOs) and many healthofficials, are extending support and guidance to project
Axshya at various level of implementation.
Holistic approachProject Axshya envisages a holistic approach towards
TB care and control. It does so by engaging communitiesthrough a strategy of Advocacy, Communication andSocial Mobilization. This model of Community
engagement aims at the impartation of knowledge aboutTuberculosis and services. This thereby generates ademand for services from communities. On the otherhand, it also supports health systems in catering to theservice demand that is thus generated. The Union haspartnered with multiple stakeholders the Governmentof India, politicians, community members, civil societyorganizations and many others, who are willing tocontribute for a cause that is to have a TB - Free
society.
(Project Axshya-Programme Management Unit, The GlobalFund Round 9 TB Project, The Union South-East Asia Office,
-
7/29/2019 Health Action: Special issue on TB (March 2013)
11/40
Health Action March 2013 11
COVER
STORY
The National Strategic Plan for TB Control for
2012-17 developed by the Union Ministry of
Health and Family Welfare has raised the bar
for tackling the fast- growing TB epidemic in the
country. Revised National TB Control Programme hasmade historical achievements in the recent past years
and the programme stands at the point where achieving
the ambitious goal of Universal Access to TB Care is
in sight. The programme has been continuously been
innovative and progressive in addressing issues related
to TB control in the country.
The National Strategic Plan (2012-2017) was
prepared through a consultative process involving a wide
cross-section of stakeholders and experts in the
programme. Innovation and consensus were the
highlights of the process adopted for development ofthe National Strategic Plan.
National Strategic Plan (2012-2017)With progress in achieving objectives in the 11th Five-
Year Plan and defining newer targets of Universal
Access to TB care, newer strategies have beendeveloped as a comprehensive National Strategic Planunder the 12th Five-Year Plan of the Government of
India. The following thrust areas were identified:
Strengthening and improving the quality of basic
Evolving TB Control
Strategies in India(Universal access to early quality diagnosis
and care of tuberculosis)
DOTS services Further strengthening and aligning with health system
under NRHM Deploying improved rapid diagnosis at the field level Expanding efforts to engage all care providers Strengthening urban TB Control Expanding diagnosis and treatment of drug resistant
TB
Improving communication and outreach Promoting research for development and
implementation of improved tools and strategies.
Strategic vision to move towards
universal accessThe vision of the Government of India is for a TB-
free India with reduction of the burden of the disease
until it is no longer a major public health problem. Toachieve this vision, the programme has now adopted
the new objective of Universal access for qualitydiagnosis and treatment for all TB patients in the
community. This entails sustaining the achievementsof the programme to date, and extending the reach andquality of services to all persons diagnosed with TB.
The objectives of the programme proposed in the planare:
To achieve 90% notification rate for all cases To achieve 90% success rate for all new and 85%
for re-treatment cases To significantly improve the successful outcomes of
treatment of Drug Resistant TB Cases To achieve decreased morbidity and mortality of HIV
associated TB To improve outcomes TB care in the private sector
PROPOSED STRATEGIES IN THE
NATIONAL STRATEGIC PLAN 2012-2017:
Case-finding and Diagnostics: Early identification of all infectious TB cases.
Improved integration with the general health system,
The rich technical and managerial
capabilities of the programme with the
support from all stakeholders aiming
towards Universal Access to TB Care
will ensure that the programme is able to
overcome all challenges successfully and
will contribute to developing a healthy and
economically productive population.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
12/40
Health Action March 2013 12
and leverage field staff for home-based case finding.
Improve communication and outreach
Screen clinically and socially vulnerable risk groups
for TB. Develop improved sputum collection and
transportation systems. Deployment of higher-sensitivity diagnostic tests for
TB suspects (and incorporate new tests) and
decentralized DST services Catch patients already diagnosed through notification
from all sources, improved referral for treatment
mechanisms, and deployment of Laboratory &Private Provider notification
Patient-friendly Treatment Services Promptly and appropriately treating TB, increasingly
guided by DST.
Making DOTS more patient-friendly throughincreased communitization of DOT; pilot incentives/
offsets for patient costs to help patients completetreatment and better monitoring through InformationTechnology.
Improving partnerships between public and privatesector Establish Indian Standards for TB Carewhich can be used to engage providers using existingprivate treatment and improve care with some publicsector support and supervision.
Research will guide improvements in regimens and
delivery systems. National Treatment Committee/TWG for regular
review of regimens, all treatment- related technical
guidance
Scale-up of Programmatic Management of DrugResistance -TB Developing network of C&DST Laboratories and
Strengthening of Reference Laboratories Decentralized DST at the district level for early MDR
detection Improved information system for PMDT Humanpower support for additional workload by
aligning with NRHM health blocks and rationalizationof number of patients per STS
Improved drug management of second-line anti-TBdrugs (22% of budget, even at low GOI procurementcost)
Scale -up of Joint TB-HIV Collaborative Activities: Activities will aim at early, rapid TB diagnosis with
high sensitivity tests for HIV-infected TB suspects& ART for all HIV-infected TB patients, with
transport support.
Integration with Health Systems: Integrating the RNTCP with the overall health system
will increase effectiveness and efficiencies of TB
care and control which has been depicted in thepicture.
In rural areas, the RNTCP can focus integrationthrough the National Rural Health Mission.
In urban areas, the RNTCP can integrate throughthe private sector and the evolving National UrbanHealth Mission.
Engagement of Private Sector: Private sector engagement essential for universal
access and early detection RNTCP set norms and conduct surveillance while
maintaining some flexibility Move from sensitization model today to output- based
contracting of services through interface/ aggregators States need to experiment with innovation and scale-
up of those models that are successful
Inclusion of private laboratories and pharmacists todetect patients at earliest points of care
Technical working group (for guidance, policy advice) Technical support unit (for assistance to States for
contracting) Accreditation and innovative financing
Human Resource Development The goal of RNTCPs HRD strategy is to optimally
utilize available health system staff to deliver quality
TB services, and to strengthen the supervisory andmanagerial capacity of programme staffs overseeingthese services.
RNTCP will align more effectively with health systemunder NRHM to leverage field supervisory staff moreeffectively, and increase capacity building of staffs
to equip them to handle multiple tasks of DOTS,MDR-TB, TB/HIV.
Support cells at State and District levels will be
The vision of the Government of India is
for a TB-free India with reduction of the
burden of the disease until it is no longer a
major public health problem. To achievethis vision, the programme has now
adopted the new objective ofUniversal
access for quality diagnosis and treatment
for all TB patients in the community.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
13/40
Health Action March 2013 13
strengthened to increase administrative and
managerial capacity, creating space for localprogramme managers to focus on supervision andquality of services.
Web based application will be developed for creatingdynamic HRD database to assist better planning andfacilitate faster communication.
Advocacy, Communication and SocialMobilization: Generating demand for earlier diagnosis and
treatment Community ownership, participation and involvement
are essential for universal access.
Enhancing the ACSM capacity of service providersto improve the quality of service delivery.
ACSM can reduce stigma which is critical foruniversal access.
Increased coverage can be achieved by focusing onat risk and clinically, socially and occupationally
vulnerable populations.
Monitoring and Evaluation, Surveillance andImpact Assessment: Case-Based Web-Based application will be
developed for real time data entry to enhanceprogramme management and better decision-making.
Relevant, timely and accurate data collection at eachlevel of programme and the healthcare system.
Analysis of these data is critical for ensuring continual
programmatic improvement.
Research to inform TB Control policy and practice: Operational research will be promoted to optimize
TB control Priority research agenda to be developed.
Conduct or commission priority
researchRapidly translate lessons intoinnovative policy and practice
Web-based application for faster
feedback to the Principal Investigatorsand facilitate monitoring of the processof proposal submission and thedecisions of respective committees
Key Interventions: Strengthening and improving the
quality of basic DOTS services Further strengthen and align with
health system under NRHM Deploying improved rapid diagnosis
at the field level
Expanding efforts to engage all careproviders
Strengthening urban TB Control
Expanding diagnosis and treatment of drugresistant TB
Improving communication and outreach
Promoting research for development and
implementation of improved tools and strategies.
What will NSP achieve? Control TB: compared to todays activities, success
will :
Accelerate decline in incidence and prevent 22lakh TB cases
Reduce TB deaths by 75%, and save 17 lakh
lives from TB
Contain MDR TB: avert 1 lakh MDR cases
and reduce incidence by 50%
Return on investment: For each additional $1
1$ buys quicker diagnosis of more TB patients,
more effective treatment
~14$ gained [ongoing analysis being done here]
in future direct economic expenditure on TB
cases prevented and Leadership for India: Sustain Indias global leadership
in TB treatment and control
The rich technical and managerial capabilities of the
programme with the support from all stakeholders aiming
towards Universal Access to TB Care will ensure
that the programme is able to overcome all challenges
successfully and will contribute to developing a healthy
and economically productive population.
(Central TB Division, Ministry of Health and Family Welfare,
Government of India)
-
7/29/2019 Health Action: Special issue on TB (March 2013)
14/40
Health Action March 2013 14
COVER
STORY
I
ndia has the highest TB burden in the world,accounting for one-fifth of all new TB cases andtwo-thirds of the cases in South and South-East Asia.
While India has made great strides in addressing TB,many challenges remain to expanding case-detectionand treatment. Involvement of the private sector incase-detection, TB awareness and prevention, andpromotion of safe and effective TB treatment practicesis vital to the continued success of Indias RevisedNational TB Control Programme (RNTCP). Workplaceinterventions could be one potential private-sector entrypoint for reaching the unreached clients at workplacefor TB diagnosis, treatment and care.
The World Economic Forum reports that managersaround the world are more ill-informed about
tuberculosis (TB) in their workplaces than about HIVand AIDS. 63% of firms in low-income countries expectsome impact from TB in the next five years comparedto 46% of all firms expecting some impact from HIV/AIDS. Prevalence of TB is about 3 times higher amongsmokers.
TB Alert India initiated TB workplace interventionsin ACSM project supported by USAID and World Visionin October 2008. During the project period (Oct 2008 Sept 2010), TB Alert India withits local partner organizationscarried out 68 sensitizationworkshops at workplaces andreached out to more than 3000employees in 5 districts. Theproject facilitated in placing TBworkplace Policy andCommitments from the 25Industries. The workplacesincluded Tobacco companies,Steel factories, Stone crushingunits, Granite companies, Cargocompany/Mosquito coil company-
Tuberculosis and
Silicosis at WorkplaceA Situational Analysis Study in seven districts of Axshya India
Project in Andhra Pradesh
NET Slab Industries,Rice Millers Association.
TB Alert India continued TB workplace interventionsin Axhsya Project from October 2010 with the support
of Global Fund through World Vision in reaching out tomore than 1600 employees in 40 Industries. Secretary,Labour Employment Training and Factories Department(LET&FD) & State TB Officer identified 6 vulnerablesegment industries which are prone to chest diseases.These vulnerable segment industries are Stone Crushers,Cement Companies, Jute Mills, Brick Kilns, Quarriesand Mines. A situational analysis study was taken upby TB Alert India on the suggestion of Secretary, LabourEmployment Training and Factories Department(LET&FD) and State TB Officer. Assessment was
taken up under New Initiatives of TB Alert India underAXSHYA India Project supported by World Vision &Global Fund.
Situational analysis study
TB Workplace Intervention Situational Analysis Studycarried out by TB Alert India in identified 54 industries(Stone Crushing Units(25), Brick Kilns (11), CementMaking Unit(3), Glass Manufacturing Unit (3),Foundries(12)) in 7 districts (Hyderabad, Ranga Reddy,
Medak, Nalagoda, Chittoor,Prakasham, Khammam) ofAndhra Pradesh State. Thestudy was carried out with 528employees and 41 focal persons(Owner/CEO/Director/ Sr.Manager) in the industry.
The objectives of study wereto assess awareness levels ofemployees at workplace ontuberculosis and silicosis; tounderstand attitudes ofemployees at workplacetowards TB and silicosis and to
-
7/29/2019 Health Action: Special issue on TB (March 2013)
15/40
Health Action March 2013 15
assess the interest of stakeholders of workplace inbecoming part of TB and silicosis control.
Major findings of the studyMajority of permanent employees constituted
Cement, Glass Manufacturing Industries and Foundries(90 %( 162), 83%(55), 76%(77)) respectively.Temporary employees were those from brick kilns andstone-crushing units. Employees of stone-crushing unitsand brick kilns are not enrolled with ESI. More numberof employees enrolled under ESI are in Foundries60%(61) followed by Glass Manufacturing 37% (25)& Cement Industries 18%(32). About 37% of therespondents, who are at the risk of getting TB have notheard of TB. However, among the respondents whoare aware of TB, only 32% have listed out correctsymptoms of tuberculosis, further only 10% of the
respondents who have listed correct symptoms of TBknow that DOTS is the treatment for it. Percentage ofrespondents with TB in family stands at 11% amongtotal respondents questioned. However, stigma attachedto TB is less where 60% expressed that they will feelcompassionate to TB patients.
Employees expressing the need to carry out morehealth camps at workplaces stands at 50%. Healthawareness programmes are a necessity which shouldcover TB/Silicosis, other non-communicable diseasesat workplace. As large as 55% of employees acrossthe industries are of the opinion that their industries havea role in the prevention of TB, and silicosis at theirworkplace. Health awareness programmes whichinclude TB, HIV, Malaria and other diseases like BP,sugar, and cancer should be carried out.
Interactions with focal persons atindustries
About 41 focal persons at the industries wereinterviewed by TB Alert India. Out of a total 41respondents, 83% (34) of focal persons feel that thyneed help of NGOs for greater liaison with GovernmentHealth Services for better Workplace and Community
Health Services. Dispensaries at workplace, doctorvisiting the work place on call are the arrangements insome industries to deal with minor alignments. However,as large as 61% of the industries, mostly brick kilns andstone-crushing units dont have any such arrangementat work places. 73% (30) expressed interest in takingup health activities at workplaces with the support ofNGOs.
RecommendationsIn liaison with the Director of Factories, Director of
Medical Insurance and Commissioner of Labour, State
TB Officer, there is a need to talk to managements ofindustries and plan a cascading model of sensitizationprogrammes to employees (From top management toworker level) on TB, HIV, Malaria, Silicosis, andLifestyle Diseases. Sensitizing ESI hospital / dispensary
staff on RNTCP is crucial for enhancing outreachactivities. Establishing/strengthening linkages betweenDistrict Inspector of Factories, District HealthAuthorities, Labour Department and ESI Hospital /Dispensaries is an important aspect to be taken upimmediately. Where large numbers of employees arepresent, there is a need for establishment of Sputum-Collection Centres/DMC/ICTC at workplace.Employee workforce services can be utilized forspreading disease awareness, referral services andfollow-up of patient, advocating with workplace
management for workplace policy on health (TB, HIV,Malaria, Silicosis, Lifestyle diseases) using IBAmaterials.
ConclusionFor better health of employees, interventions need to
be identified to raise awareness about TB, HIV, HIV-TB co-infections, silicosis, non-communicable diseases(lifestyle diseases like Hypertension, Diabetes, Cancer,Heart diseases) on symptoms as well as availability oftreatment facilities.
As health activities of industries are limited to merehealth camps, the scope of diseases and frequency of
health activities need to be increased. There is a greaterneed to establish linkages between workplaces andGovernment health services. Further efforts need to bemade to rope in industries and volunteers at workplacefor facilitation of disease-specific policies at the industrylevel by establishing linkages with district healthauthorities. There needs to be sustained effort andgreater involvement of industries in carrying out health-related activities at workplaces. There is also a greaterneed for tripartite linkages as well as effort industries, Department of Factories/ Labour and StateDistrict Health Authorities.
Limitations of studyA number of limitations to the methodological approach
were identified which include the following: Available employees in the respective department
were called for the study as per the sample The sample group was restricted to 10% based on
availability of resources and time Capacity of District staff for efficient translation of
questions and interpretation of responses was limitedin some areas.
(Axshya India Team of TB Alert India, Hyderabad)
-
7/29/2019 Health Action: Special issue on TB (March 2013)
16/40
Health Action March 2013 16
LEPRA Society (India), a national NGO, has field
and clinic-based activities for TB control, carried
out in partnership with Revised National TB
Control Programme (RNTCP). In response to revisedNGO schemes, it has further expanded the partnership
to offer laboratory services of MDR TB.
LEPRA Indias foray into Tuberculosis
Control ProgrammeLEPRA Indias participation in tuberculosis control
programme has been justified by a combination of
factors: The expertise that has been built in the field
workers all through the years needed to be channelled.
Also, the reappearance of tuberculosis as an epidemic
and the similarity in diagnosis and need of regular
treatment in both tuberculosis and leprosy warrantedparticipation in tuberculosis control programme. In
addition, field-level education and counselling that
LEPRA India is equipped with could be utilized to create
an impact on allied areas like TB and HIV/AIDS.
LEPRA Indias Participation in TB control
programmes is in five different ways:
Direct participation in TB control
Capacity-building
Advocacy, Communication and Social Mobilization
(ACSM)
Research activities Field / laboratory Publications
COVER
STORY Experiences of LEPRA
India in TB Control inAndhra PradeshDr. J. Subbanna* and Dr. Aparna S Srikantam**
In Andhra Pradesh, there are 12 Designated
Microscopy Centres (DMCs) including one Tuberculosis
Unit (TU) of LEPRA India, which is being implemented
in partnership with RNTCP under signed NGO schemescovering a population of 12.3 lakh population.These
DMCs are situated in Hyderabad, Rangareddy, Adilabad
and Krishna districts. During 2012, the performance of
these centres is as follows:
The annualized total case-detection is 2262 with
ANCDR as 187/lakh of which 1018 were new
sputum-positive-cases and all were initiated on
DOTS. This includes 110 paediatric cases (4.9%),
and 243 TB cases which were found to be HIV +ve
(11%).
The sputum conversion rate was 93% and cure ratewas 88% and defaulter rate 2.9%.
236 children were provided INH prophylaxis
121 new MDR TB diagnosis (for Sikkim) and 3230
MDR TB cases follow-up sputum examinations (for
AP and Sikkim) done at BPHRC
Three-hundred-and-eighty local private health care
providers in the DMCs/TUs were sensitized and
involved in referrals of TB suspects and in provision of
DOTS. Capacity-building activities in TB was provided
to PHC/UHP staff and TB sensitization for involvement
was carried out with local private health care providers
(380), DOTS providers (1170) and target groups like
Private Practitioners (Sensitization) TB Patients (Discussions)TB Forum Members (Discussions)
-
7/29/2019 Health Action: Special issue on TB (March 2013)
17/40
Health Action March 2013 17
self-help groups, youth clubs, AWWs, village volunteers,
tribal leaders, teachers, students, local NGOs/CBOs/
FBOs and VHSC members.
Community awareness programmes consisted of film
shows, group meetings, observation days, folk art /stage
plays by local artists. Supported the DTCS in
implementing tribal action plan and participated in
monthly and quarterly review meetings with the staff
concerned and DTCS. Support was provided to DTCS
in implementing awareness programmes with LEPRA
IEC vans.
LEPRA India is the NGO member in the District TB
Control Society (DTCS) and State TB Control Society
in the implementing states and districts.
LEPRA India-Blue Peter Public Health and
Research Centre (BPHRC) has undergone aformal accreditation process between 2007 and 2009and entered into a memorandum of understanding
(MoU) with the State TB Control Programme of the
Government of Andhra Pradesh.
Microbiology Division of BPHRCwith a provision for
BSL III and accredited to the Central TB Division, GoI,
has been taking part in the MDR case-detection and
monitoring from 2009 onwards.
The laboratory caters to the diagnostic needs of
patients from BPHRC, other LEPRA field projects,
RNTCP-DOTS plus phase-II districts of AP (E.
Godavari, W. Godavari, Guntur & Krishna), Sikkim andAP Chest Hospital (for extra pulmonary TB patients).
The laboratory performs about 2000 cultures each year.
Since 2009, the lab confirmed the MDR status of around
500 out of 1200 clinically suspected patients through
these lab tests. Diagnosis of extra-pulmonary TB is of
special focus covering specimens like fine needle
aspirates, urine, endometrial aspirates and pleural fluids
for diagnosing TB. The laboratory recently was
accredited to perform line probe assay for rapid
detection of MDR TB. Operational research on second
line anti-TB drug resistance and genotyping has been
undertaken in the division in collaboration with and
funding from AP State TB office.
Current research interests of the division include
diagnosis and epidemiological features of drug resistance
in TB (such as geography-related prevalence and
correlation with treatment outcome); diagnosis,
epidemiology and pathogenesis of extra pulmonary TB.(lymph node TB) and molecular epidemiology of TB.
Attempts are being made to identify potential new
diagnostic markers specific to Mycobacterium
tuberculosis.
At present, in BPHRC there are
5 PhD students pursuing work in TB and TB-HIV
6 ongoing research projects in TB and TB-HIV
During the last couple of years, 6 research papers on
TB and TB-HIV from BPHRC were published in
various international journals.
(*Director- LEPRA India BPHRC; ** Group Leader-
Microbiology Division, LEPRA India BPHRC)
Case-StudiesMr. Kamruddin, a 50-year-old male, and resident of Bhavaninagar, was suffering with persistent cough and fever. He
approached a private doctor, who diagnosed it as TB and started Anti-TB Treatment (irregular treatment/doses) for 9
months. Even after 9 months, the symptoms persisted. After that, he went to Osmania General Hospital. In the DMC, they
did sputum examination, and the result was positive (3+). They referred (transferred) him to DMC Bhavaninagar for
Anti TB treatment and he was put on DOTS (Cat II, Relapse as per the transfer letter by the Medical Officer - DMC
Osmania General Hospital). After three months follow-up of sputum test the result was positive and was given prolonging
pouches for one month. Thereafter, the sputum test result was negative. During his phase of treatment, he refused to
continue treatment (defaulted-5/6/2009). In one months time, he became serious and was admitted to AP Chest
Hospital on 8/7/2009. After two months follow-up, sputum test was done. The result was found positive (2+). Later inthe last follow-up, sputum test was found positive (1+). He was suspected of MDR TB and his sputum sample was sent to
AP Chest Hospital for diagnosis. They confirmed it as MDR case and started DOTS PLUS treatment and completed
successfully.
Arshiya, 16 year-old daughter of Mr. Khamruddin, was suffering from stomach pain, cough, fever and she went toOsmania General Hospital. Sputum examination was done and the result was found positive (2+). They referred her to
DMC Bhavaninagar for DOTS, LEPRA registered her and put on Cat I (new case) on 19/10/2009. Sputum examinations
were done in a routine manner and all the results were negative. Completing treatment she was declared as cured. She
came back to the DMC Bhavaninagar with cough, fever and body pains again and her sputum examination result was
positive (2+). She was put on DOTS as Cat II (Relapse). The same day she was suspected for MDR TB and the sputum
sample was sent to AP Chest Hospital for diagnosis of MDR. She was diagnosed as MDR TB at AP Chest Hospital and
put on DOTS Plus treatment and is continuing treatment.
(DJS & DAS)
-
7/29/2019 Health Action: Special issue on TB (March 2013)
18/40
Health Action March 2013 18
Tuberculosis (TB) is one of the most under-
reported and underrated chronic diseases of
children across the world. Although childhood TB
has been receiving attention from global health experts,it still remains a major cause for illness and death of
children. TB is preventable, treatable and curable.
Children generally contract this disease because they
are in proximity to elders who are already affected by
the TB bacterium such as a nanny, mother, the care-
giver or other infected family members.
Children are the prime targets as their immune
systems are not fully developed. Children with TB are
often poor and live in vulnerable communities where
there may be lack of access to health care. According
to the Stop TB Partnership, newborn infants of womenaffected with TB are at increased risk of contracting
TB. Children living with adults suffering from TB can
become ill with the disease even if they are vaccinated
with the BCG vaccine. Tuberculosis among children is
often overlooked due to non-specific symptoms and
difficulties in diagnosis such as obtaining sputum from
young children.
COVER
STORY TB In Children
An Avoidable Problem
Dr Shoma A Chatterji
TB preys on vulnerable childrenThe World Health Organization (WHO)s Global
Tuberculosis Control Report, 2012, estimates that
490,000 children fall sick with TB every year and nearly70,000 of them die. Experts, however, maintain that
these are gross underestimates. TB preys on the most
vulnerable children the poor, the malnourished and
those living with HIV. This leads to an unimaginable
burden on children and their families.
In a Papua New Guinea village, a two-year old orphan
who was infected and whose mother died of the disease,
was taken up for adoption by a school teacher. But all
stories do not end happily. Another adult patient, who
later died of multidrug-resistant TB (MDR-TB), had
told me that he was tormented by guilt because thereare no resources to help them care for their children
while they are being treated at a hospital or at home. In
another case, a stock-out of anti-TB medication in
Southern Romania prevented one 14-year-old boy from
leaving the Bucharest hospital to take his high school
exams, says a Ph.D. student of Medical Anthropology
of the City University of New York.
The only TB vaccine that exists, namely the BCG
(Bacillus Calmette-Guerin), was invented in 1921. In
most countries across the world, BCG is mandatorily
It goes without saying that the more cost-
effective way is to prevent the disease than
to cure it. The most effective way to
prevent childhood TB is to stop it fromspreading. This can be done through what
is known as the three Is (i) Intensified
Case-Finding, (ii) Isonaizid Preventive
Therapy or IPT and (iii) Infection Control.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
19/40
Health Action March 2013 19
given at (or soon after) birth to infants to protect them
from the most severe forms of TB including TB
meningitis. But few are aware that (a) BCG does not
protect children from the most common form of TB
TB of the lungs and (b) the effect of the vaccine wears
off as children grow in age. Besides, children with
HIV cannot receive BCG because it can make them
sick.
Scientists are working on developing new vaccines
that address these drawbacks. A dozen new vaccine
candidates are currently undergoing clinical studies.
Results of a study of a preventable TB vaccine, that
enrolled nearly 3000 infants in South Africa, were
published very recently in 2013, and were disappointing
because the vaccine did not significantly protect children
against TB. Collaboration between the public and privatesectors is urgently called for to ensure adequate
investment to develop and deliver a new safe and
effective TB vaccine soon.
Investing in safe and effective vaccinesEvaline Kibuchi, from the Kenya National Aids NGOs
Consortium (an ACTION partner) says, The Ministryof Health needs to increase contact tracing for adultswith TB. It is the best way to find children who havebeen exposed and it is not happening enough.
It goes without saying that the more cost-effective
way is to prevent the disease than to cure it. The mosteffective way to prevent childhood TB is to stop it fromspreading. This can be done through what is known asthe three Is (i) Intensified Case-Finding, (ii) IsonaizidPreventive Therapy or IPT and (iii) Infection Control.
Intensified Case Findingimplies that when an adultmember in the family is diagnosed with TB, all closecontacts and family members, including children mustbe screened for TB. If symptomatic, they should beprovided appropriate diagnosis and treatment. IPTprevents children from developing the active disease
which is also important in the case of children livingwith HIV. Children with HIV are 20 times more likely
to develop TB than children with healthy immunesystems.
Infection Control covers high burden areas wherechildren are more likely to be exposed to the TB bacteria
such as health care facilities, crches, homes, schools
and other community settings that need to be made
TB-safe. This includes separation of patients who
are coughing from those who are not; providing them
with masks; opening windows and doors to establish
natural ventilation all of which can prevent the
spread of the disease. These methods, endorsed by
the WHO, can prove to be very effective in reducingchildhood TB.
It is also necessary to train health workers to
address childhood TB and TB services which need
to be incorporated into the Integrated Management
of Childhood Illnesses (IMCI) a broad-based
childhood health strategy.
It is also important to link TB services with maternal
health care to prevent mother-to-child transmission
of HIV and TB. All children living with HIV must be
screened for TB regularly,, and vice versa during
visits to the medical centre.
Addressing povertyIn order to end childhood TB, we must address
poverty. Child health is directly linked to povertya
major risk factor for TB which in turn, is a big driver
of poverty. This functions like a vicious circle leading
back to where it began. Children living in poverty
are more likely to be undernourished, lack access to
medical care and live in crowded homes with little
ventilation and poor hygiene. Their parents are also
likely to be ignorant about medical treatment,
importance of hygiene and preventive and curativehealth strategies in daily life, which in turn makes
such children more vulnerable to TB than others.
Then again, people living in impoverished conditions
often cook indoors which creates an environment of
thick smoke for the child that weakens their lungs. A
study in Bangladesh found that children who
completed primary school were less likely to
develop TB.
(The author is a freelance journalist, film scholar and writer
based in Kolkata, India, and has authored 17 books)
The World Health Organization (WHO)s
Global Tuberculosis Control Report,
2012, estimates that 490,000 children fall
sick with TB every year and nearly 70,000
of them die. Experts, however, maintain
that these are gross underestimates. TB
preys on the most vulnerable children
the poor, the malnourished and those
living with HIV. This leads to an
unimaginable burden on children and their
families.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
20/40
Health Action March 2013 20
Although TB is a completely curable disease, there
is still considerable social stigma attached to the
disease. Some of the basis of this stigma is
related to the perception that tuberculosis is a disease
that is related to being unclean, poverty or evenhereditary. There is also a misperception of risk of
transmission to their contacts at home or work even
though the patients are on regular treatment.
Social impact of TB stigmaThe social stigma related to TB leads to a situation
wherein patients refuse to seek treatment till at an
advance stage, and discontinue treatment, stop going
for work and get ostracized by the family and
community. Women are prevented from getting married
or are divorced by husbands.
Overcoming stigmaThe main strategy to overcome the stigma is to give
education that is tailored to the community and the
patients/ family in particular. At the community level ,
constant emphasis that TB is another airborne disease
that is not related to a persons hygiene or economic
status is an important step to address the communitys
anxiety. Apart from this, the emphasis that TB can be
completely cured if detected early and treated effectively
is a major positive point that should be highlighted
constantly. Public testimonies by community leaders /
COVER
STORY
Social Stigma Attached to TB
Dr G Srinivas Rao, MD
celebrities affected by TB and individuals who have
successfully completed their treatment constitute
another useful strategy that can be used to destigmatize
the disease.
Familys supportAt the personal level, joint counselling of the individual
and the family members will go a long way to dispel
misperceptions that sleeping together, sharing cutlery
and socializing spread the disease. It should be clearly
stated that the risk of TB transmission is minimal after
being diagnosed and started on treatment. It is to be
emphasized that the greatest transmission risk is
BEFORE the patient is diagnosed and hence the need
for contact examination.
Employers supportIf deemed necessary, the employers should also be
counselled in a similar way so as to reassure them that
the patient is no longer a health risk to his co-workers
and to ensure that his employment status is not affected
by being treated for TB. Laws are available to prevent
workers from being unfairly dismissed for being treated
for curable diseases such as TB.
Communitys supportRecognizing the great impact social stigma can have
on the effectiveness of the National TB Control
Programme, AXSHYA has taken several communityinitiatives such as disseminating correct technical
information on TB, printing educational pamphlets and
organizing community shows, exhibitions and talks to
reduce the stigma of being diagnosed with TB. Medical
staff treating TB patients are also sensitized to be aware
of the possible social stigma attached to being diagnosed
with TB and actively enquire about the issues and
manage them effectively, if recognized.
(National Manager, CHAI Axshya Project,
The Catholic Health Association of India, Secunderabad))
-
7/29/2019 Health Action: Special issue on TB (March 2013)
21/40
Health Action March 2013 21
What is tuberculosis?
Tuberculosis (TB) is an infectious disease caused by
a bacterium, Mycobacterium tuberculosis.
How is tuberculosis caused?
TB is spread through the air by a person sufferingfrom TB. A single patient can infect 10 or morepeople in a year.
What are the symptoms of tuberculosis?
Common symptoms of tuberculosis include: Cough for three weeks or more, sometimes
with blood-streaked sputum Fever, especially at night Weight loss
Loss of appetite
Benefits of DOTS/ Why DOTS? More than doubles the accuracy of TB
diagnosis. Its success rate is up to 95%. It prevents the spread oftuberculosis by
prioritizing sputum-positive patients for
diagnosis and treatment, thus reducing theincidence and prevalence of TB.
It helps in alleviating poverty by saving lives,reducing the duration of illness and preventingnew infectious cases.
It improves quality of care and removes stigma. It prevents treatment failure and the emergence
of MDR-TB by ensuring patient adherence totreatment and uninterrupted supply of anti -TBdrugs.
It lends credence to TB control efforts and thehealth care system.
What is DOTS that is being implemented?
The DOTS strategy is in practicein more than 180 countries. ByMarch 2006, India had extendedDOTS to the entire country.
What is RNTCP?Revised National TuberculosisControl Programme (RNTCP)applies the principles of DOTSto the Indian context.
How many people die from
TB in India every year?
Frequently-Asked Questions
on TuberculosisTuberculosis is one of the leading causes of mortalityin india. It kills more than 300,000 people in Indiaevery year.
Which is the strongest risk factor for tuberculosis
among adults and how does it affect the spread
of TB?
The Human Immunodeficiency Virus (HIV, the virus
that causes AIDS) is the strongest risk factor for
tuberculosis among adults. Tuberculosis is one of theearliest opportunistic diseases to develop amongst
persons infected with HIV. HIV debilitates the
immune system increasing the vulnerability to TB and
increasing the risk of progression from TB infection
to TB disease. An HIV positive person is six times
(50-60% life time risk) more likely to developing
tuberculosis once infected with TB bacilli, as
compared to an HIV negative person, who has a
10% life-time risk.
Can tuberculosis be cured in HIV co-infection?
Tuberculosis can be cured, even among HIV-infectedpersons. TB treatment with DOTS reduces the
morbidity and mortality among people living with HIV.
For how long must tuberculosis treatment be
taken?
Tuberculosis requires at least 6 months of treatment.
What is multi-drug-resistant tuberculosis?
Multi-drug-resistant tuberculosis (MDR TB) is
caused by strains of the tuberculosis bacteria resistant
to the two most effective anti-tuberculosis drugs
available-isoniazid and rifampicin. MDR TB can only
be diagnosed in a specialized laboratory. What is the duration
of treatment for multi-drug-
resistant tuberculosis?
M u l t i - d r u g - r e s i s t a n t
tuberculosis requires at least 18-
24 months of treatment with
medicines which are 100 times
more expensive and often highly
toxic.
(Source: TBC India)
COVER
STORY
-
7/29/2019 Health Action: Special issue on TB (March 2013)
22/40
Health Action March 2013 22
The core objective of the Baseline Survey wastogather baseline information on TB-relatedKnowledge, Attitudes and Practices (KAP) among thefive respondent groups and gain a better understandingof how target groups viewed stigma discrimination andgender.
Methodology: The survey was implemented by TheUnion, South-East Asia Regional office in 30 of the 374Global Fund project districts. The districts were selected
by a stratified cluster sampling technique from the statesof the four zones (north, south, east and west) of thecountry. Nearly 75,000 households were visited covering
a population of 374,000 people.
Axshya is a Global Fund supported TB projectlaunched in 2010 that is reaching out to 374 districtsacross 23 states in the country to expand the reach and
visibility of the RNTCP through increased civil societyengagement at the community and the individual levelswith a special focus on marginalized and vulnerable
populations.
Key findingsEach respondent group was interviewed through a
semi- structured questionnaire.
General populationAs many as 4562 persons (2320 males and 2242
females) with an average age of 34-36years were interviewed. Therespondents included labourers,housewives, skilled workers and peopleengaged in agriculture. Students, petty
traders and those in government andprivate service were also interviewed.30% of the respondents were illiterate
and 60% stayed in semi pucca orkachha (temporary) houses.
Findings Almost 15% of the respondents had
absolutely not heard of TB at all
COVER
STORY Knowledge, Attitudes and
Practices on TB
Of those who had heard of TB, 69% recognizedcough for two or more weeks as a major symptomwhile 11 % did not know any symptoms of TB
50% knew TB was transmitted through air when
an infected person coughed/ sneezed 55% felt sputum examination could help diagnose
TB while 60% considered chest X -Ray to be moreaccurate.
Though 80% felt that TB was curable, only 37%knew that TB treatment has to be taken for 6-8months duration
Only 23% had heard of the term DOTS, and less
than a fifth (19%) knew that free treatment fortuberculosis is available under DOTS
10% of the respondents had cough of 2 weeks or
more in the last 2 months and of them only about
30% had visited any health care provider seekingcare
TB diseased personsAs many as 752 TB diseased persons were identified
and 609 were interviewed. Among the respondents,around 77% were married, 43% were illiterate and 33%
worked as daily wage labourers. Importantly 89% usedsolid fuel for cooking and 75% were from householdswith less than Rs 4,000 monthly income.
Findings 66% patients had cough as a
presenting symptom, 47% had feverand 33% chest pain 74% patients were diagnosed withTB within one month of the onset ofsymptoms 60% were diagnosed in agovernment hospital 54% were receiving free treatmentunder DOTS and 46% were takingtreatment from non-Government health
facilities by paying for their medicines
From a Baseline Survey conducted as part of Project Axshya
-
7/29/2019 Health Action: Special issue on TB (March 2013)
23/40
Health Action March 2013 23
While 80% were aware that treatment has to be
taken regularly, only 55% knew that the duration ofTB treatment is for 6-8 months
Health Service Providers (HSP)
About 614 Health Service Providers were interviewedout of which nearly 2/3rds were private practitionersand 1/3rd were doctors in government service. More
than half of them (55%) were qualified practitioners ofallopathic medicine, 26% were qualified practitionersof Ayurveda medicine, 12% were qualified practitioners
of homeopathic medicine and 5% were practitioners ofUnani system of medicine and the remaining were notqualified in any of the systems of medicine mentionedabove.
Findings 94% HSPs identified cough of two weeks, 64%
coughing of blood and 52% pain in the chest as major
symptoms of TB 1/5th of the HSPs did not know that patients can be
sent to government health facilities for sputum
examination Nearly 96% had diagnosed a case of TB of the lungs
in the past and 36% mentioned that they haddiagnosed TB of other organs as well
88% believed that allopathic medicines were the bestform of medicines for the treatment of TB, 10%
informed that homeopathic medicines are good for
TB treatment, and 2% felt that other forms ofmedicines work for TB.
80% were aware that the treatment for TB is for 6-8 months
Nearly 1/3rd of HSPs did not advise TB patients togo to government health facilities for availing freetreatment
64% were not sure what was multidrug resistant TB
(MDR- TB) and how it is diagnosed.
Opinion LeadersAs many as 511 leaders were interviewed. Opinion
leaders influencers in the community, holding sway overpeople propagating messages and instilling behaviorsthrough discourses, interactions and exchanges. Therespondents manly consisted of members of local selfgovernment-Panchayati Raj Institutions (village pradhan,ward member), religious leaders and teachers.
Findings All of the respondents had heard of TB and 92%
knew it, fully curable 91 % knew a person with TB must be referred to
government health centre 67% had faith in allopathic medicine while 34%
advocated for DOTS. However, 7% also felt herbalremedies could cure TB, 6.5% viewed Ayurveda asa good option and 4.3% said that they also believe
that homeopathy works. Only 1/5th of them had undertaken any activities
related to TB control in their community.Non-Governmental Organisations/Community-Based Organisations
As many as 51 NGOs/CBOs were identified in the300 primary sampling units of the 30 districts. They were
selected on the basis of information given by opinionleaders and community members about their presencein their locality. These NGOs/CBOs were working in
the area of education (55 sanitation (43%), ruraldevelopment (33%), domestic violence gender (35%),employment (14%) and environment (4%).
FindingsAbout 50% were engaged in programmes on TB
prevention and control.
Of those who were engaged in TB Control, 88%created awareness on TB, 23% reduced stigma anddiscrimination and provided training on TB health care
Nearly, 84% were willing to collaborate with RNTCPwhereas only 41 % were involved in any of theschemes
12 % helped in the resettlement of TB patients andonly worked as DOTS providers.
ConclusionThis community based survey provides valuable
information on the current levels of knowledge, attitudesand practices of the various stakeholders of the
population with respect to TB. This report provides datathat shows major gaps and opportunities for enhancingthe reach, visibility and access to Government of
Indias Revised National TB Control Programme withinthe framework of the ACSM component of Global FundRound 9 India TB project.
(For the full text of the report, visit: http://www.axshya-
theunion.org/Documents/KAP.pdf.)
Axshyais a Global Fund supported TB
project launched in 2010 that is reaching out
to 374 districts across 23 states in the
country to expand the reach and visibility of
the RNTCP through increased civil societyengagement at the community and the
individual levels with a special focus on
marginalized and vulnerable populations.
-
7/29/2019 Health Action: Special issue on TB (March 2013)
24/40
Health Action March 2013 24
World TB Day is an opportunity to raise
awareness about the burden of tuberculosis
(TB) worldwide and the status of TB
prevention and control efforts. It is also an opportunity
to mobilize political and social commitment for further
progress.
Key facts about TB Tuberculosis (TB) is second only to HIV/AIDS as
the greatest killer worldwide due to a single infectious
agent.
In 2011, 8.7 million people fell ill with TB and 1.4
million died from TB.
Over 95% of